This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Opinion: Discussing the potential of Abbott's Proclaim XR SCS system which was recently approved for the treatment of diabetic peripheral neuropathy.

Ticker(s): ABT

Who's the expert?

Institution: Pacific Pain Management

  • CEO and double board-certified physician in Pain Management and Anesthesiology at Pacific Pain Management, a multidisciplinary pain center in Ventura, California.
  • 20 years experience in interventional pain management and spinal cord stimulation.
  • Extensive experience implanting spinal cord stimulation devices for the treatment of diabetic peripheral neuropathy. 

Interview Questions
Q1.

How many SCS devices do you implant monthly for DPN?

Added By: chanell_admin
Q2.

How many of those diabetic peripheral neuropathy patients do you see on a monthly basis right now?

Added By: slingshot_insights
Q3.

At what point do patients start considering some medical options, and do all patients at least try medications prior to a stimulation system? 

Added By: slingshot_insights
Q4.

Patients can have those systems tested prior to being implanted. What does that process look like?

Added By: slingshot_insights
Q5.

What has been your preferred stimulation system in the past, and has that changed at all with the recent labels? 

Added By: slingshot_insights

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.